Bayer Schering Pharma AG et al v. Lupin Ltd et al
Filing
91
ORDER granting Defendants Lupin Limited's and Lupin Pharmaceutical's Motion #89 to File Under Seal Certain "Confidential" Exhibits Accompanying the Supplemental Declaration of Kate M. Lesciotto in Support of Lupin's Motion for Summary Judgment that the Claims of the U.S. Reissue Patent are Invalid as Obvious #88 . Signed by Magistrate Judge Robert J. Johnston on 7/26/11. (Copies have been distributed pursuant to the NEF - ECS)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
James E. Whitmire, Esq. (NV Bar No. 6533)
SANTORO, DRIGGS, WALCH,
KEARNEY, HOLLEY & THOMPSON
400 S. Fourth Street, Third Floor
Las Vegas, NV 89101
Telephone: 702-791-0308
Facsimile: 702-791-1912
jwhitmire@nevadafirm.com
Of Counsel:
Robert F. Green
Christopher T. Griffith
Salim A. Hasan
Kate M. Lesciotto
LEYDIG, VOIT & MAYER, LTD.
Two Prudential Plaza, Suite 4900
180 N. Stetson Avenue
Chicago, IL 60601-6731
Telephone: 312-616-5600
Facsimile: 312-616-5700
rgreen@leydig.com
cgriffith@leydig.com
shasan@leydig.com
klesciotto@leydig.com
Attorneys for Defendants Lupin Limited
and Lupin Pharmaceuticals, Inc.
17
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF NEVADA
18
19
20
BAYER SCHERING PHARMA AG &
BAYER HEALTHCARE
PHARMACEUTICALS INC.,
21
Plaintiffs,
22
23
24
v.
LUPIN LIMITED and LUPIN
PHARMACEUTICALS, INC.,
25
Defendants.
Civil Case No. 2:10-cv-1166-KJD-RJJ
DEFENDANTS LUPIN LIMITED’S AND
LUPIN PHARMACEUTICALS, INC.’S
MOTION TO FILE UNDER SEAL
CERTAIN “CONFIDENTIAL” EXHIBITS
ACCOMPANYING THE
SUPPLEMENTAL DECLARATION OF
KATE M. LESCIOTTO IN SUPPORT OF
LUPIN’S MOTION FOR SUMMARY
JUDGMENT THAT THE CLAIMS OF
THE U.S. REISSUE PATENT ARE
INVALID AS OBVIOUS (DKT. 88-2)
26
27
28
-108837-01/Motion to Seal - Lupin's Reply.doc
1
Pursuant to the Protective Order in the above-captioned case (Dkt. 17), Defendants Lupin
2
Limited and Lupin Pharmaceuticals, Inc. (collectively, “Lupin”) seek leave to file under seal
3
certain confidential exhibits accompanying the Supplemental Declaration of Kate M. Lesciotto in
4
Support of Lupin’s Motion for Summary Judgment That The Claims Of The U.S. Reissue Patent
5
Are Invalid As Obvious (Dkt. 88-2) (“Supplemental Lesciotto Declaration”). In support of this
6
Motion, Lupin states as follows:
7
1.
The Protective Order in this case permits each party to designate certain
8
information produced during discovery as "CONFIDENTIAL" if the designating party
9
reasonably believes that the information should be protected from public disclosure. (Dkt. 17 at
10
2-3.) The Protective Order further specifies that the parties may file documents under seal under
11
an order of this Court for cause shown. (Id. at 13).
12
2.
Certain exhibits attached to the Supplemental Lesciotto Declaration consist of
13
documents or contain citations to documents, that the parties have designated as
14
“CONFIDENTIAL” in this case.
15
16
17
3.
Lupin therefore seeks leave of the Court to file certain exhibits accompanying the
Supplemental Lesciotto Declaration under seal.
4.
In addition, Lupin has concurrently filed a public version of the exhibits to the
18
Supplemental Lesciotto Declaration which redacts only those exhibits that need to remain
19
confidential under the protective order. Specifically, Lupin seeks leave to file under seal Reply
20
Exhibits 2 and 4.
21
22
23
24
25
26
27
28
-208837-01/Motion to Seal - Lupin's Reply.doc
1
Dated this 25th day of July, 2011.
SANTORO, DRIGGS, WALCH,
KEARNEY, HOLLEY & THOMPSON
2
3
/s/ James E. Whitmire
James E. Whitmire (NV Bar No. 6533)
SANTORO, DRIGGS, WALCH, KEARNEY,
HOLLEY & THOMPSON
400 S. Fourth Street, Third Floor
Las Vegas, NV 89101
Telephone: 702-791-0308
Facsimile:
702-791-1912
jwhitmire@nevadafirm.com
4
5
6
7
8
9
Of Counsel:
Robert F. Green
Christopher T. Griffith
Salim A. Hasan
Kate M. Lesciotto
Leydig, Voit & Mayer, Ltd.
Two Prudential Plaza, Suite 4900
180 N. Stetson Avenue
Chicago, IL 60601-6731
Telephone: 312-616-5600
Facsimile:
312-616-5700
rgreen@leydig.com
cgriffith@leydig.com
shasan@leydig.com
klesciotto@leydig.com
10
11
12
13
14
15
16
17
18
Attorneys for Defendants Lupin Limited
and Lupin Pharmaceuticals, Inc.
19
20
21
22
IT IS SO ORDERED.
_____________________________
UNITED STATES MAGISTRATE JUDGE
DATE: JULY 26, 2011
23
24
25
26
27
28
-308837-01/Motion to Seal - Lupin's Reply.doc
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?